Clinical and Preclinical Pipeline Overview
BiTEŽ Antibody Pipeline Overview
Micromet's goal is to build a well-staged pipeline of highly differentiated products for the treatment of cancer, inflammation and autoimmune disease. All drug candidates are derived from antibodies.
Scientific Publications
